ESMO 2024

ESMO 2024

Update: 2024-09-19
Share

Description

Recapping just some of the notable data coming out of ESMO 2024:
-Final OS results from Keynote-522 (perioperative pembrolizumab in TNBC)
-AMBASSADOR (adjuvant pembrolizumab in bladder cancer)
-NIAGRA (perioperative durvalumab in bladder cancer)
-ADRIATIC (discussed on ASCO recap Pod, but publication now available)
-LEANOX (impact of lean body mass adjustment on oxaliplatin dose)
Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

ESMO 2024

ESMO 2024

John Bossaer